Endocrine Associates of Long Island, P.C. — Smithtown, New York

Endocrine Associates of Long Island, P.C. is a clinical research site located in Smithtown, New York, United States 11787.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Endocrine Associates of Long Island, P.C. has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Hypoparathyroidism, Acromegaly, Fibromyalgia.

Sponsors: Takeda, Novartis Pharmaceuticals, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Endocrine Associates of Long Island, P.C.?

Endocrine Associates of Long Island, P.C. has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Endocrine Associates of Long Island, P.C. conducted?

Endocrine Associates of Long Island, P.C. has 4 clinical trials on record, with 2 currently active. Their work covers Hypoparathyroidism, Acromegaly, Fibromyalgia.

Is Endocrine Associates of Long Island, P.C. accredited by Crixeo Health?

Endocrine Associates of Long Island, P.C. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Endocrine Associates of Long Island, P.C.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.